AK Medical Holdings Limited (HKG:1789)

AK Medical Holdings Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	339.09	273.93	182.1	204.77	92.62
Depreciation & Amortization	105.57	94.77	88.89	78.44	71.54
Other Amortization	1.31	1.56	2.05	1.96	2.62
Loss (Gain) From Sale of Assets	0.63	2.27	0.17	0.13	0.52
Asset Writedown & Restructuring Costs	-	-	-	18.36	-
Stock-Based Compensation	7.63	8.78	5.06	8.13	1.05
Provision & Write-off of Bad Debts	22.05	21.58	13.7	10.49	-1.11
Other Operating Activities	-24.15	-19.56	-22.5	-39.03	-21.64
Change in Accounts Receivable	-139.54	-69.67	3.33	-26.82	23.12
Change in Inventory	29.45	106.85	-193.18	20.74	-62.36
Change in Accounts Payable	47.82	-30.05	19.75	62.4	-53
Change in Unearned Revenue	-17.18	17.61	5.45	-87.57	121.01
Change in Other Net Operating Assets	23.29	43.02	-70.89	-9.09	2.25
Operating Cash Flow	395.98	451.07	33.94	242.92	176.62
Operating Cash Flow Growth	-12.21%	1229.22%	-86.03%	37.54%	-13.95%

Investing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-105.67	-152.82	-183.8	-115.2	-58.76
Sale of Property, Plant & Equipment	1.01	0.39	0.31	0.06	2.89
Sale (Purchase) of Intangibles	-18.31	-9.15	-12.28	-6.52	-17.47
Investment in Securities	-202.86	-256.6	-141.02	20.78	-236.39
Other Investing Activities	21.22	24.83	18.63	18.58	12.63
Investing Cash Flow	-304.61	-393.35	-318.15	-82.29	-297.1

Financing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	78.38	49.7	58.8	-	-
Total Debt Issued	78.38	49.7	58.8	-	-
Long-Term Debt Repaid	-89.53	-41.32	-18.43	-10.72	-12.79
Total Debt Repaid	-89.53	-41.32	-18.43	-10.72	-12.79
Net Debt Issued (Repaid)	-11.15	8.38	40.38	-10.72	-12.79
Issuance of Common Stock	2.74	0.94	8.93	0.06	0.22
Repurchase of Common Stock	-	-	-	-	-49.83
Common Dividends Paid	-73.63	-46.1	-61.51	-23.96	-36.69
Other Financing Activities	-3.43	-2.65	-1.82	-2.17	-1.61
Financing Cash Flow	-85.47	-39.43	-14.02	-36.8	-100.7

Net Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.84	2.66	3.62	26.39	-16.3
Net Cash Flow	5.06	20.96	-294.61	150.22	-237.49

Free Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	290.31	298.25	-149.86	127.72	117.86
Free Cash Flow Growth	-2.66%	-	-	8.36%	-1.79%
Free Cash Flow Margin	19.58%	22.15%	-13.70%	12.14%	15.48%
Free Cash Flow Per Share	0.26	0.27	-0.13	0.11	0.10
Levered Free Cash Flow	-23.63	285.75	-154.43	129.07	40.55
Unlevered Free Cash Flow	-21.79	286.33	-153.63	130.43	41.56

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	0.45	0.92	1.29	2.17	1.61
Cash Income Tax Paid	51.59	41.62	46.07	57.21	29.06
Change in Working Capital	-56.16	67.74	-235.53	-40.34	31.03

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 1, 2026

Data Sources Report a data error